Virtual Analytical Summit 2020: Full meeting agenda
Register now to join world-leading researchers online, March 31-April 2, as the global science industry pulls together at this critical time
Register now to join world-leading researchers online, March 31-April 2, as the global science industry pulls together at this critical time
Read this exclusive interview with Louise Kenny, one of the founding directors of the INFANT Centre, to discover how they are using mass spectrometry to research preeclampsia and pre-term birth
Dr. Josephine Bunch, UK Grand Challenge awardee, describes her unprecedented research into a tumor’s intricate architecture and shares her ultimate goal of mapping what’s inside a tumor
AEOL 10150 is currently the only drug being developed by BARDA to address the delayed effects of radiation exposure
Cast your vote in the 2026 Scientists' Choice Awards for the product that has made the most difference to your lab
Presentations on Open Aperture, Apertura's material transfer agreement program, describe how open academic access to TfR1 CapX can unlock innovation and collaboration across the field
New PTC Harmony thermal cycler line expands access to reliable, high‑performance PCR across academic and biopharma laboratories
Learn how CancerTools.org is rewriting how cancer research tools move from lab benches to scientists around the world, and how the profits are put straight back into fighting cancer
A study led by Karl Landsteiner University shows that the disease affects whole-brain communication networks, and that this may help predict survival
A next-generation PCR system designed to help labs manage increasing workflow complexity with greater flexibility, speed and confidence in reproducible results
Molecular diagnostics experts share why EQCs are no longer optional if you’re looking to elevate your molecular diagnostics
New portfolio enhancements reflect Bruker’s commitment to advancing integrated, high‑performance solutions that support laboratories in addressing evolving infectious disease challenges
In research conducted in mice, scientists identified a trio of existing medicines as promising candidates for treating a rare and severe form of infant leukemia caused by a genetic changed called KMT2A::AFF1
Oxford researcher Nina Dimova pushes pixel-by-pixel calibration and clustering to unlock nanosecond precision in particle tracking and electron microscopy
Prospective study published in Clinical Cancer Research shows that women >70 who tested Signatera MRD-negative could avoid surgery and remain progression-free
Vote for the products that have made the most difference to your research for the chance to win a $100 Amazon Gift Card (or equivalent currency)